Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Pulmonary hypertension: the future has begun].

Horst Olschewski1

  • 1Abteilung für Pulmonologie, Medizinische Universitätsklinik, Medizinische Universität, Graz, Osterreich. horst.olschewski@meduni-graz.at

Medizinische Klinik (Munich, Germany : 1983)
|April 12, 2006
PubMed
Summary

Pulmonary hypertension research is advancing with new drug classes and improved diagnostics. Future treatments may include targeted therapies and better diagnostic tools for earlier detection.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sex differences in long-term survival of COPD patients following initiation of home non-invasive ventilation after acute hospitalization due to respiratory failure.

Respiration; international review of thoracic diseases·2026
Same author

Functional characterization of <b><i>KCNA5</i></b> gene variants linked to pulmonary arterial hypertension.

The European respiratory journal·2026
Same author

Prognostic Value of Exercise Testing in Patients with Liver Cirrhosis.

Diagnostics (Basel, Switzerland)·2026
Same author

Update on pulmonary hypertension.

Respiratory research·2026
Same author

Noninvasive mean pulmonary arterial pressure/oxygen uptake slope as a predictor of pulmonary exercise haemodynamics and outcome.

ERJ open research·2026
Same author

The Clinical Relevance of Unclassified Pulmonary Hypertension.

Chest·2026

Area of Science:

  • Cardiology
  • Pulmonology
  • Pharmacology

Background:

  • Pulmonary hypertension (PH) research has intensified due to effective treatments and better understanding of disease mechanisms.
  • Current PH pharmacotherapy relies on prostanoids, endothelin receptor antagonists, and phosphodiesterase 5 inhibitors.

Purpose of the Study:

  • To review current and emerging therapeutic strategies for pulmonary hypertension.
  • To highlight the importance of improving early diagnosis and awareness for pulmonary hypertension.

Main Methods:

  • Literature review of current and investigational treatments for pulmonary hypertension.
  • Discussion of diagnostic advancements and awareness initiatives.

Main Results:

  • Established drug classes (prostanoids, ERAs, PDE5 inhibitors) are mainstays of PH treatment.
  • Emerging therapies include tyrosine kinase inhibitors, EGF/PDGF receptor blockers, VIP, and rho-kinase inhibitors.

Conclusions:

  • Future PH treatment may involve targeted therapies and drugs addressing endothelial dysfunction.
  • Enhanced diagnostic sensitivity, specificity, and awareness programs are crucial for early PH detection.

Related Experiment Videos